Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Veradermics completes IPO; begins trading on NYSE under ticker “MANE”

by mariel | Feb 4, 2026 | Portfolio News

Veradermics closed an oversubscribed Series C in 4Q25 and subsequently completed its IPO, with shares beginning to trade under ticker MANE.

Boston Scientific completes acquisition of Nalu Medical

by mariel | Jan 27, 2026 | Portfolio News

Nalu’s acquisition by Boston Scientific was completed after quarter-end; LVP2 reported receiving $26.4mm in proceeds.

IntelyCare acquires CareRev to expand clinical labor solutions across acute and post-acute care

by mariel | Jan 8, 2026 | Portfolio News

IntelyCare completed the acquisition of CareRev, creating a broader workforce platform; the combined business generated >$200M pro forma revenue in CY2025.

Zenas BioPharma reports positive Phase 3 INDIGO registrational results for obexelimab in IgG4-RD

by mariel | Jan 5, 2026 | Portfolio News

Zenas reported positive Phase 3 INDIGO results and indicated plans to submit a BLA in 2Q26 and MAA in 2H26.

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2026 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer